‘Dune 3’ and ‘Avengers: Doomsday’ in Stand-Off Over Same Release Date: “Somebody’s Gotta Move”

Dec. 18 has been claimed by both Warner Bros./Legendary's Dune: Part Three and Disney/Marvel's Avengers: Doomsday, creating a direct box-office showdown; Dune holds three weeks of IMAX exclusivity. Dune: Part Two made ~$750M globally and Avengers: Endgame made ~$2.8B, so both films are expected to be major draws, but IMAX/PLF allocation and screen cannibalization could reduce premium-format revenue for Disney and pressure exhibitors' scheduling. Studios are standing firm on the date, implying potential short-term volatility in theater PLF revenues and exhibit allocations over the key pre-Christmas window.

Analysis

The real profit lever here is premium-format scarcity rather than headline attendance: a relatively small shift of PLF/IMAX capacity (low hundreds of screens globally) can reallocate a disproportionate share of holiday ticket revenue because PLF per-screen averages and F&B attach rates run materially higher than regular auditoria. A three-week exclusivity window amplifies that leverage — IMAX/PLF owners can extract higher pricing and multiple showtimes in a short, high-demand period, turning a modest screen count advantage into a near-term revenue and margin inflection for IMAX and large exhibitors.

For a diversified studio, the second-order cost is loss of optionality. When premium windows are ceded, studios may be forced to accept lower box office shares or accelerate downstream monetization (streaming/ PVOD) to recoup economics, compressing theatrical gross-to-net conversion rates for the quarter. That dynamic makes short-term theatrical misses more likely to show up in 1–2 quarter operating results even if franchises perform cumulatively well over a 12–18 month cycle.

Smaller distributors and specialty releases are the forgotten downside: when two tentpoles hoover up PLF screens and first-weekend mindshare, indie windows and art-house seasonal slate revenue can drop 30–60% in the same weeks, tightening cashflows for theaters dependent on counterprogramming. Near-term catalysts to watch are opening-weekend PLF sell-through rates, IMAX seat yield per show (vs. seasonal baseline), and social sentiment velocity (spoiler-driven front-loading) — any one can quickly re-rate revenue expectations within 7–21 days post-release.

Key Decisions for Investors

• Long IMAX (IMAX) — buy shares or a defined-risk call spread now through Dec 10 to capture the premium-format holiday revenue window. Position size: 2–4% of portfolio. Target: +15–25% upside into late-Jan earnings if PLF sell-through beats seasonal baselines; hard stop: -10% intra-position loss.
• Paired trade — long IMAX / hedge with a DIS put spread: buy IMAX (1–2% portfolio) and buy a 3-month DIS put spread (sell lower strike) sized at 50% notional to the IMAX position to monetize asymmetric near-term theatrical risk to Disney. Rationale: monetizes PLF upside while capping downside if Disney’s opening-week share is impaired; expected P/L window: 1–3 months.
• Tactical options for risk-defined exposure — if you prefer limited capital outlay, buy a calendar call spread on IMAX (near-term Dec/Jan buy calls + sell Mar calls) to exploit elevated implied vol through the holiday and collect Theta after the opening weekend. Target a 2.5:1 reward-to-risk on debit paid; close 2–3 trading days after weekend box office prints.
• Avoid naked short DIS equity — instead use modest, time-boxed put spreads (3 months) or short-dated collar structures. Disney is too diversified for an outright short; cap downside with spreads and size conservatively (<=1% portfolio) because upside from streaming/merch/global licensing could reprice quickly if Avengers overperforms.